Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain Metastases

NCT02654106 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Brain Metastases

Interventions

RADIATION: Fractionated Stereotactic Radiotherapy
DRUG: Temozolomide

Sponsor

Chinese Academy of Medical Sciences

Collaborators

[object Object]